HIV/AIDS
Findings from the United States advance knowledge in HIV/AIDS research
Published in AIDS Weekly, September 25th, 2006
Study 1: Preferential infection shortens the lifespan of HIV-1-specific CD4+ T cells.
"CD4+ T-cell help is essential for effective immune responses to viruses. In human immunodeficiency virus (HIV) infection, CD4+ T cells specific for HIV are infected by the virus at higher frequencies than other memory CD4+ T cells," researchers in the United States report.
According to the authors, "Here, we demonstrate that HIV-specific CD4+ T cells are barely detectable in most infected individuals and that the corresponding CD4+ T cells exhibit an immature phenotype...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-09-25)
More Articles from AIDS Weekly
- HIV/AIDS & Tuberculosis
Mannose-binding lectin deficiency related to lower HIV and tuberculosis risk - HIV/AIDS HAART
HIV RNA suppression improved with three-drug/two-class regimen including efavirenz - HIV/AIDS HAART
Monocyte chemoattractant protein 1 mutated allele confers better response to protease inhibitors - HIV/AIDS HAART
Saquinavir lipid-based formulation improves bioavailability - HIV/AIDS Prognostics
CD4 percent predicts survival when CD4 count is 200-350 cells/mcL during HAART initiation - Amphotericin B Toxicity
Amphotericin B-related nephrotoxicity increases hospital stay in immunocompromised patients - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
